223 related articles for article (PubMed ID: 27679845)
1. ERK5 kinase activity is dispensable for cellular immune response and proliferation.
Lin EC; Amantea CM; Nomanbhoy TK; Weissig H; Ishiyama J; Hu Y; Sidique S; Li B; Kozarich JW; Rosenblum JS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11865-11870. PubMed ID: 27679845
[TBL] [Abstract][Full Text] [Related]
2. ERK5: structure, regulation and function.
Nithianandarajah-Jones GN; Wilm B; Goldring CE; Müller J; Cross MJ
Cell Signal; 2012 Nov; 24(11):2187-96. PubMed ID: 22800864
[TBL] [Abstract][Full Text] [Related]
3. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors.
Lochhead PA; Tucker JA; Tatum NJ; Wang J; Oxley D; Kidger AM; Johnson VP; Cassidy MA; Gray NS; Noble MEM; Cook SJ
Nat Commun; 2020 Mar; 11(1):1383. PubMed ID: 32170057
[TBL] [Abstract][Full Text] [Related]
5. Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation.
You I; Donovan KA; Krupnick NM; Boghossian AS; Rees MG; Ronan MM; Roth JA; Fischer ES; Wang ES; Gray NS
Cell Chem Biol; 2022 Nov; 29(11):1630-1638.e7. PubMed ID: 36220104
[TBL] [Abstract][Full Text] [Related]
6. Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5.
Nguyen D; Lemos C; Wortmann L; Eis K; Holton SJ; Boemer U; Moosmayer D; Eberspaecher U; Weiske J; Lechner C; Prechtl S; Suelzle D; Siegel F; Prinz F; Lesche R; Nicke B; Nowak-Reppel K; Himmel H; Mumberg D; von Nussbaum F; Nising CF; Bauser M; Haegebarth A
J Med Chem; 2019 Jan; 62(2):928-940. PubMed ID: 30563338
[TBL] [Abstract][Full Text] [Related]
7. Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo[e]pyrimido-[5,4-b]diazepine-6(11H)-ones.
Deng X; Elkins JM; Zhang J; Yang Q; Erazo T; Gomez N; Choi HG; Wang J; Dzamko N; Lee JD; Sim T; Kim N; Alessi DR; Lizcano JM; Knapp S; Gray NS
Eur J Med Chem; 2013; 70():758-67. PubMed ID: 24239623
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4.
Myers SM; Miller DC; Molyneux L; Arasta M; Bawn RH; Blackburn TJ; Cook SJ; Edwards N; Endicott JA; Golding BT; Griffin RJ; Hammonds T; Hardcastle IR; Harnor SJ; Heptinstall AB; Lochhead PA; Martin MP; Martin NC; Newell DR; Owen PJ; Pang LC; Reuillon T; Rigoreau LJM; Thomas HD; Tucker JA; Wang LZ; Wong AC; Noble MEM; Wedge SR; Cano C
Eur J Med Chem; 2019 Sep; 178():530-543. PubMed ID: 31212132
[TBL] [Abstract][Full Text] [Related]
9. Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation.
Morimoto H; Kondoh K; Nishimoto S; Terasawa K; Nishida E
J Biol Chem; 2007 Dec; 282(49):35449-56. PubMed ID: 17928297
[TBL] [Abstract][Full Text] [Related]
10. Structural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and Bromodomains.
Wang J; Erazo T; Ferguson FM; Buckley DL; Gomez N; Muñoz-Guardiola P; Diéguez-Martínez N; Deng X; Hao M; Massefski W; Fedorov O; Offei-Addo NK; Park PM; Dai L; DiBona A; Becht K; Kim ND; McKeown MR; Roberts JM; Zhang J; Sim T; Alessi DR; Bradner JE; Lizcano JM; Blacklow SC; Qi J; Xu X; Gray NS
ACS Chem Biol; 2018 Sep; 13(9):2438-2448. PubMed ID: 30102854
[TBL] [Abstract][Full Text] [Related]
11. Alternative ERK5 regulation by phosphorylation during the cell cycle.
Iñesta-Vaquera FA; Campbell DG; Tournier C; Gómez N; Lizcano JM; Cuenda A
Cell Signal; 2010 Dec; 22(12):1829-37. PubMed ID: 20667468
[TBL] [Abstract][Full Text] [Related]
12. Dual role of ERK5 in the regulation of T cell receptor expression at the T cell surface.
Rovira-Clavé X; Angulo-Ibáñez M; Tournier C; Reina M; Espel E
J Leukoc Biol; 2016 Jan; 99(1):143-52. PubMed ID: 26302753
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation Is Required for ERK5 Nuclear Translocation and ERK5-Mediated Cancer Cell Proliferation.
Erazo T; Espinosa-Gil S; Diéguez-Martínez N; Gómez N; Lizcano JM
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32209980
[TBL] [Abstract][Full Text] [Related]
14. Basic fibroblast growth factor promotes glial cell-derived neurotrophic factor gene expression mediated by activation of ERK5 in rat C6 glioma cells.
Obara Y; Nemoto W; Kohno S; Murata T; Kaneda N; Nakahata N
Cell Signal; 2011 Apr; 23(4):666-72. PubMed ID: 21130871
[TBL] [Abstract][Full Text] [Related]
15. Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.
Tatake RJ; O'Neill MM; Kennedy CA; Wayne AL; Jakes S; Wu D; Kugler SZ; Kashem MA; Kaplita P; Snow RJ
Biochem Biophys Res Commun; 2008 Dec; 377(1):120-5. PubMed ID: 18834865
[TBL] [Abstract][Full Text] [Related]
16. ERK5 activation is essential for osteoclast differentiation.
Amano S; Chang YT; Fukui Y
PLoS One; 2015; 10(4):e0125054. PubMed ID: 25885811
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cellular functions by the ERK5 signalling pathway.
Wang X; Tournier C
Cell Signal; 2006 Jun; 18(6):753-60. PubMed ID: 16376520
[TBL] [Abstract][Full Text] [Related]
18. EGCG Suppresses ERK5 Activation to Reverse Tobacco Smoke-Triggered Gastric Epithelial-Mesenchymal Transition in BALB/c Mice.
Lu L; Chen J; Tang H; Bai L; Lu C; Wang K; Li M; Yan Y; Tang L; Wu R; Ye Y; Jin L; Liang Z
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27447666
[TBL] [Abstract][Full Text] [Related]
19. Erk5 inhibits endothelial migration via KLF2-dependent down-regulation of PAK1.
Komaravolu RK; Adam C; Moonen JR; Harmsen MC; Goebeler M; Schmidt M
Cardiovasc Res; 2015 Jan; 105(1):86-95. PubMed ID: 25388666
[TBL] [Abstract][Full Text] [Related]
20. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
